Comorbidities and co-infections in people living with HIV/AIDS
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Rev Rene (Online) |
DOI: | 10.15253/2175-6783.2014000600006 |
Texto Completo: | http://periodicos.ufc.br/rene/article/view/3286 |
Resumo: | It is a cross-sectional study made in three clinics specialized in the care of infectious diseases in Ribeirão Preto, SP, Brazil, in order to identify the prevalence of co-infections and comorbidities in people living with HIV / AIDS. Demographic and clinical variables were analyzed from 498 medical records of patients from December, 2004 to June, 2010. Data analyzed using descriptive statistics show an average of 39.3 years of age, ranging from 17 to 71 years, with 295 (59.2%) males. 390 comorbidities were observed (78.3%), especially dyslipidemia 126 (25.3%), triglycerides 68 (13.7%), hepatitis C 68 (13.7%), oral candidiasis 60 (12.0 %), sexually transmitted disease 57 (11.4%) and tuberculosis 51 (10.2%). Depending on the different comorbidities, it is considered appropriate that special strategies to monitor are planned, for the diagnosis and early intervention. |
id |
UFC-16_a1d74e5b59b68f846732259e02c711bc |
---|---|
oai_identifier_str |
oai:periodicos.ufc:article/3286 |
network_acronym_str |
UFC-16 |
network_name_str |
Rev Rene (Online) |
spelling |
Comorbidities and co-infections in people living with HIV/AIDSMorbidityHIVAcquired Immunodeficiency SyndromeAnti-Retroviral AgentsIt is a cross-sectional study made in three clinics specialized in the care of infectious diseases in Ribeirão Preto, SP, Brazil, in order to identify the prevalence of co-infections and comorbidities in people living with HIV / AIDS. Demographic and clinical variables were analyzed from 498 medical records of patients from December, 2004 to June, 2010. Data analyzed using descriptive statistics show an average of 39.3 years of age, ranging from 17 to 71 years, with 295 (59.2%) males. 390 comorbidities were observed (78.3%), especially dyslipidemia 126 (25.3%), triglycerides 68 (13.7%), hepatitis C 68 (13.7%), oral candidiasis 60 (12.0 %), sexually transmitted disease 57 (11.4%) and tuberculosis 51 (10.2%). Depending on the different comorbidities, it is considered appropriate that special strategies to monitor are planned, for the diagnosis and early intervention.Universidade Federal do Ceará2014-12-21info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://periodicos.ufc.br/rene/article/view/328610.15253/2175-6783.2014000600006Rev Rene; Vol 15 No 6 (2014)Rev Rene; v. 15 n. 6 (2014)2175-67831517-3852reponame:Rev Rene (Online)instname:Universidade Federal do Ceará (UFC)instacron:UFCenghttp://periodicos.ufc.br/rene/article/view/3286/2525Copyright (c) 2016 Northeast Network Nursing Journalinfo:eu-repo/semantics/openAccessRighetto, Rosângela CasasReis, Renata KarinaReinato, Lílian Andreia FleckGir, Elucir2018-12-05T19:34:52Zoai:periodicos.ufc:article/3286Revistahttp://periodicos.ufc.br/renePUBhttp://periodicos.ufc.br/rene/oairene@ufc.br||2175-67831517-3852opendoar:2018-12-05T19:34:52Rev Rene (Online) - Universidade Federal do Ceará (UFC)false |
dc.title.none.fl_str_mv |
Comorbidities and co-infections in people living with HIV/AIDS |
title |
Comorbidities and co-infections in people living with HIV/AIDS |
spellingShingle |
Comorbidities and co-infections in people living with HIV/AIDS Comorbidities and co-infections in people living with HIV/AIDS Righetto, Rosângela Casas Morbidity HIV Acquired Immunodeficiency Syndrome Anti-Retroviral Agents Righetto, Rosângela Casas Morbidity HIV Acquired Immunodeficiency Syndrome Anti-Retroviral Agents |
title_short |
Comorbidities and co-infections in people living with HIV/AIDS |
title_full |
Comorbidities and co-infections in people living with HIV/AIDS |
title_fullStr |
Comorbidities and co-infections in people living with HIV/AIDS Comorbidities and co-infections in people living with HIV/AIDS |
title_full_unstemmed |
Comorbidities and co-infections in people living with HIV/AIDS Comorbidities and co-infections in people living with HIV/AIDS |
title_sort |
Comorbidities and co-infections in people living with HIV/AIDS |
author |
Righetto, Rosângela Casas |
author_facet |
Righetto, Rosângela Casas Righetto, Rosângela Casas Reis, Renata Karina Reinato, Lílian Andreia Fleck Gir, Elucir Reis, Renata Karina Reinato, Lílian Andreia Fleck Gir, Elucir |
author_role |
author |
author2 |
Reis, Renata Karina Reinato, Lílian Andreia Fleck Gir, Elucir |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Righetto, Rosângela Casas Reis, Renata Karina Reinato, Lílian Andreia Fleck Gir, Elucir |
dc.subject.por.fl_str_mv |
Morbidity HIV Acquired Immunodeficiency Syndrome Anti-Retroviral Agents |
topic |
Morbidity HIV Acquired Immunodeficiency Syndrome Anti-Retroviral Agents |
description |
It is a cross-sectional study made in three clinics specialized in the care of infectious diseases in Ribeirão Preto, SP, Brazil, in order to identify the prevalence of co-infections and comorbidities in people living with HIV / AIDS. Demographic and clinical variables were analyzed from 498 medical records of patients from December, 2004 to June, 2010. Data analyzed using descriptive statistics show an average of 39.3 years of age, ranging from 17 to 71 years, with 295 (59.2%) males. 390 comorbidities were observed (78.3%), especially dyslipidemia 126 (25.3%), triglycerides 68 (13.7%), hepatitis C 68 (13.7%), oral candidiasis 60 (12.0 %), sexually transmitted disease 57 (11.4%) and tuberculosis 51 (10.2%). Depending on the different comorbidities, it is considered appropriate that special strategies to monitor are planned, for the diagnosis and early intervention. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-12-21 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://periodicos.ufc.br/rene/article/view/3286 10.15253/2175-6783.2014000600006 |
url |
http://periodicos.ufc.br/rene/article/view/3286 |
identifier_str_mv |
10.15253/2175-6783.2014000600006 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
http://periodicos.ufc.br/rene/article/view/3286/2525 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2016 Northeast Network Nursing Journal info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2016 Northeast Network Nursing Journal |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal do Ceará |
publisher.none.fl_str_mv |
Universidade Federal do Ceará |
dc.source.none.fl_str_mv |
Rev Rene; Vol 15 No 6 (2014) Rev Rene; v. 15 n. 6 (2014) 2175-6783 1517-3852 reponame:Rev Rene (Online) instname:Universidade Federal do Ceará (UFC) instacron:UFC |
instname_str |
Universidade Federal do Ceará (UFC) |
instacron_str |
UFC |
institution |
UFC |
reponame_str |
Rev Rene (Online) |
collection |
Rev Rene (Online) |
repository.name.fl_str_mv |
Rev Rene (Online) - Universidade Federal do Ceará (UFC) |
repository.mail.fl_str_mv |
rene@ufc.br|| |
_version_ |
1822180316480012288 |
dc.identifier.doi.none.fl_str_mv |
10.15253/2175-6783.2014000600006 |